Canada markets open in 45 minutes

KORU Medical Systems, Inc. (KRMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.2400-0.0300 (-0.92%)
At close: 04:00PM EST
3.2400 0.00 (0.00%)
After hours: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close3.2700
Open3.2500
Bid2.5000 x 1300
Ask3.5900 x 800
Day's Range3.0800 - 3.3600
52 Week Range1.8200 - 3.6400
Volume20,365
Avg. Volume34,507
Market Cap146.707M
Beta (5Y Monthly)0.35
PE Ratio (TTM)N/A
EPS (TTM)-0.1310
Earnings DateFeb 28, 2023 - Mar 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.83
  • Business Wire

    KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference

    MAHWAH, N.J., November 21, 2022--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference on December 1st, 2022.

  • Business Wire

    KORU Medical Systems to Participate in Upcoming Investor Conferences

    MAHWAH, N.J., November 10, 2022--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in two upcoming investor conferences.

  • Business Wire

    KORU Medical Systems Announces 2022 Third Quarter Financial Results

    MAHWAH, N.J., November 09, 2022--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today reported financial results for the third quarter ended September 30, 2022.